Cart
sales@molnova.com
ORM-10103
CAS No. 488847-28-5
ORM-10103( —— )
Catalog No. M33047 CAS No. 488847-28-5
ORM-10103 is a novel potent and selective inhibitor of the Na+/Ca2+ exchanger (NCX).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 132 | Get Quote |
|
| 10MG | 217 | Get Quote |
|
| 25MG | 447 | Get Quote |
|
| 50MG | 719 | Get Quote |
|
| 100MG | 954 | Get Quote |
|
| 500MG | 1917 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameORM-10103
-
NoteResearch use only, not for human use.
-
Brief DescriptionORM-10103 is a novel potent and selective inhibitor of the Na+/Ca2+ exchanger (NCX).
-
DescriptionORM-10103 is a specific inhibitor of the Na+/Ca2+ exchanger (NCX), which decreases the NCX current with estimated IC50s of 55 and 67 nM at -80 and at 20 mV, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number488847-28-5
-
Formula Weight348.35
-
Molecular FormulaC20H16N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (717.67 mM; Ultrasonic )
-
SMILES[O-][N+](=O)c1ccc(Oc2ccc3OC(CCc3c2)c2ccccc2)nc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jost N, et al. ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart. Br J Pharmacol. 2013 Oct;170(4):768-78.?
molnova catalog
related products
-
CP-060
CP-060 is a potent Ca2+ antagonist and inhibits Ca2+ overload with antioxidant and cardioprotective activities.
-
Vatanidipine
Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.
-
Stugeron
Cinnarizine is a drug derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker.
